4//SEC Filing
FRATES JAMES M 4
Accession 0000950170-24-022434
CIK 0001658551other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:44 PM ET
Size
8.4 KB
Accession
0000950170-24-022434
Insider Transaction Report
Form 4
FRATES JAMES M
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-26+60,000→ 60,000 totalExercise: $17.56Exp: 2034-02-25→ Common Stock (60,000 underlying) - Award
Common Stock
2024-02-26+40,000→ 152,035 total
Holdings
- 11,072(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- [F2]Shares held by the FRATES FAMILY 2013 IRREV TRUST, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
- [F3]1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001235598
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:44 PM ET
- Size
- 8.4 KB